Dermatology Doctors in Wayne, NJ Accepting Medicare

6 Dermatology doctors found. Showing 1 - 6

Shoshannah Pollack, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1777 Hamburg Tpke, Ste 206, Wayne, NJ 07470 Phone: 973-835-1823    Fax: 973-831-7585

Diana S Leu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Ratzer Rd Ste D17, Wayne, NJ 07470 Phone: 973-925-7077    Fax: 973-925-7078

Dr. Edward Milano, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10 Route 23 South, Wayne, NJ 07470 Phone: 973-785-8585    Fax: 973-785-8095

Dr. Kuljit Chima, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 246 Hamburg Tpke, Suite 306, Wayne, NJ 07470 Phone: 973-956-0500    Fax: 973-956-0522

Dr. Herbert Simon Maier, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 220 Hamburg Tpke, Suite 22, Wayne, NJ 07470 Phone: 973-595-6338    Fax: 973-595-9446

Dr. Alice C Cardullo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Ratzer Rd, Suite B9, Wayne, NJ 07470 Phone: 973-696-4806    Fax: 973-696-8980

News Archive

Model predicts lung cancer risk

Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.

Microflex announces acquisition of Black Dragon examination gloves from MedTexx

Microflex Corporation (Lake Forest, IL), a division of BarrierSafe Solutions International® (BSSI), a leading provider of latex and synthetic barrier protection, announced the acquisition of Black Dragon® examination gloves from MedTexx in Englewood, NJ.

Walking backward could help stroke patients to walk again

Walking backward may seem counterintuitive, but to athletes in training, doing so on a treadmill builds strength and agility.

TOPCAT trial results of spironolactone presented at AHA Scientific Sessions

A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.

Scientists decode epigenetic programming of three virulent forms of acute lymphoblastic leukemia

A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL). They discovered ALL's "software" is encoded with epigenetic marks, chemical modifications of DNA and surrounding proteins, allowing the research team to identify new potential biomarkers and therapeutic targets.

Read more Medical News

› Verified 1 days ago